Journal article
Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences.
- Abstract:
-
BACKGROUND: We investigated the prognostic role of tumour-associated macrophages (TAMs) in patients with head and neck squamous cell carcinoma (HNSCC) treated with definitive chemoradiotherapy (CRT). METHODS: The expression of CD68+, CD163+ and CD11b+ cells was assessed using immunohistochemistry in n=106 pre-treatment tumour biopsy samples and was correlated with clinicopathological characteristics, including T-stage, N-stage, grading, tumour localisation, age and sex as well as local failur...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.1038/bjc.2014.446
Authors
Bibliographic Details
- Publisher:
- Cancer Research UK
- Journal:
- British journal of cancer More from this journal
- Volume:
- 111
- Issue:
- 8
- Pages:
- 1509-1518
- Publication date:
- 2014-10-01
- DOI:
- EISSN:
-
1532-1827
- ISSN:
-
0007-0920
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:479830
- UUID:
-
uuid:9fa71eda-414f-4057-8c25-5865cffd7ae2
- Local pid:
-
pubs:479830
- Source identifiers:
-
479830
- Deposit date:
-
2015-11-23
Terms of use
- Copyright holder:
- Cancer Research UK
- Copyright date:
- 2014
- Notes:
-
Copyright © 2014 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record